-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
IASLC 2020 World Conference on Lung Cancer
-
IASLC 2020 World Conference on Lung Cancer Postponed
After careful consideration of the current situation, the IASLC Board of Directors and leadership have made the decision to postpone the IASLC 2020 World Conference on Lung Cancer (WCLC 2020), which was scheduled to take place August 9 – 12, 2020, in Singapore. At this time, the World Conference on Lung Cancer has been rescheduled…
View ILCN Archives
Provider Resources
Popular Articles